Asset Dedication’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Asset Dedication's NVAX Position: Q3 2026 in Review
Asset Dedication held its Novavax (NVAX) position steady in Q3 2026 at 65 shares worth $703. The position accounts for ﹤0.01% of the portfolio, ranked #1091.
Asset Dedication first reported a position in NVAX in Q3 2022 and has held it in 17 quarters since. The position peaked at $1K in Q4 2022. 195 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.
- Asset Dedication held 65 shares of Novavax worth $703 as of Q3 2026.
- Asset Dedication left its Novavax share count unchanged in Q3 2026.
- Novavax made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #1091 holding.
- Asset Dedication first reported a position in Novavax in Q3 2022 and has held it in 17 quarters since.
- Asset Dedication's Novavax position peaked at $1K in Q4 2022.
- 195 funds tracked by Wall St. Rank held Novavax as of Q3 2026.
Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.